Fighting arthritis with a senescence gene

Nature Medicine

Volumn 5, Issue 7, 1999, Pages 731-732

  Carson, Dennis A ^a   Haneji, Norio ^a  

^a San Diego   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROLIFERATION; GENE LOCUS; HUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SENESCENCE; SHORT SURVEY; TUMOR SUPPRESSOR GENE;

ANIMALS; ARTHRITIS, RHEUMATOID; CELL AGING; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYTOKINES; HUMANS; INFLAMMATION; SYNOVIAL MEMBRANE;

EID: 0033060429     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/10447     Document Type: Short Survey

References (7)

1. INK4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis. Nature Med. 5, 760-767 (1999).
2. Serrano, M., Hannon, G.J. & Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704-707 (1993).
3. Nobori, T. et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368, 753-756 (1994).
4. Sherr, C.J. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12, 2984-2991 (1998).
5. Chin, L., Pomerantz, J. & DePinho, R.A. The INK4a/ARF tumor suppressor: One gene - two products - two pathways. Trends Biochem. Sci. 23, 291-296 (1998).
6. Stein, G.H., Drullinger, L.F., Sonlard, A. & Dulic, V. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol. Cell. Biol. 19, 2109-2117 (1999).
7. Cameron, E.E. et al. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nature Genet. 21, 103-107 (1999).